ENOB News and Press, Enochian Biosciences Inc.

2023-07-17 07:29:07 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The world of biotech stocks is notoriously difficult to predict. History is littered with companies that appeared destined for superstar status only to crash and burn. A brutal FDA approv...

2023-07-12 07:34:15 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time to start off Wednesday with an overview of all the biggest pre-market stock movers worth watching this morning! Penny stocks are dominating our pre-market stock movers ...

LOS ANGELES, June 23, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB). Enochian BioSciences Inc., a company developing gene-modified cell immunotherapies for cancer and infectious diseases, wishes to advise that its 2023 Annual Stockholder Meeting (the “Annual Meeting”), which was sched...

LOS ANGELES, June 08, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB). Enochian BioSciences Inc. (the Company) announces that it remains confident in submitting an Investigational New Drug Application (IND) for its innovative Cancer Platform in early/mid 2024 following review of comments made by the ...

2023-05-26 09:18:10 ET FTSE Russell will rebalance its indexes at the end of June and, as usual, a great deal of buying and selling will come from mutual funds and ETFs to track those changes. The preliminary list of changes came out last week, using April 28 for a cutoff date for marke...

LOS ANGELES, April 03, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- Accelerated Pre-Investigational New Drug (Pre-IND) submission to the US Food and Drug Administration (FDA) for potential cancer product due to additional promising results from studies in a commonly used mouse model ...

LOS ANGELES, March 29, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB). Enochian BioSciences Inc. (the “Company”) announces that Dr. Anahid Jewett, a renowned cancer researcher in the field of immunotherapy for cancer presented proof-of-concept data from two sets of humanized mouse stud...

2023-03-13 09:41:34 ET Enochian BioSciences ( NASDAQ: ENOB ) on Monday said the company has achieved full compliance with Nasdaq filing requirements. The company said it regained compliance by filing its annual report on form 10-K on February 27, 2023, followed by the qu...

LOS ANGELES, March 13, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) . Enochian BioSciences Inc. (the Company) announced that it has achieved full compliance with NASDAQ filing requirements. The Annual Report on Form 10-K was filed on February 27, 2023, followed by the Quarterly Reports on Forms 10...

Enochian BioSciences ( NASDAQ: ENOB ) said Thursday it got a notice from Nasdaq stating that the company remains in non-compliance with the exchange's listing rules for not filing its Form 10-Q for the period ended December 31, 2022. The notification has no immediate effect on the...